{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T21:18:15Z","timestamp":1696540695278},"reference-count":15,"publisher":"Japanese Society of Allergology","issue":"4","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T00:00:00Z","timestamp":1430265600000},"content-version":"vor","delay-in-days":2675,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergology International"],"published-print":{"date-parts":[[2008]]},"DOI":"10.2332\/allergolint.o-08-533","type":"journal-article","created":{"date-parts":[[2008,12,11]],"date-time":"2008-12-11T06:52:02Z","timestamp":1228978322000},"page":"383-390","source":"Crossref","is-referenced-by-count":19,"title":["A Double-Blind Non-inferiority Clinical Study of Montelukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, Compared with Pranlukast in Patients with Seasonal Allergic Rhinitis"],"prefix":"10.2332","volume":"57","author":[{"given":"Kimihiro","family":"Okubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohtaro","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1154","reference":[{"key":"10.2332\/allergolint.O-08-533_bb0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1139\/y95-028","article-title":"Pharmacology of montelukast sodium (Singulair), a potent and selective leukotriene D4 receptor antagonists","volume":"73","author":"Jones","year":"1995","journal-title":"Can J Physiol Pharmacol"},{"key":"10.2332\/allergolint.O-08-533_bb0010","first-page":"1921","article-title":"Clinical assessment of 0N0-1078 (pranlukast hydrate) against perennial allergic rhinitis\u2014Clinical pharmacological study using airway resistance in the nasal cavity as an indicator\u2014(A double blind comparative study using placebo as a control drug)","volume":"13","author":"Konno","year":"1997","journal-title":"J Clin TherMed"},{"key":"10.2332\/allergolint.O-08-533_bb0015","series-title":"Practical Guideline for the Management of Allergic Rhinitis in Japan\u2014Perennial Rhinitis and Pollinosis","year":"2005"},{"key":"10.2332\/allergolint.O-08-533_bb0020","series-title":"Practical Guideline for the Management of Allergic Rhinitis in Japan\u2014Perennial Rhinitis and Pollinosis","year":"2002"},{"key":"10.2332\/allergolint.O-08-533_bb0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1081-1206(10)61576-1","article-title":"Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies","volume":"92","author":"Chervinsky","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.2332\/allergolint.O-08-533_bb0030","series-title":"Nasal Allergy","first-page":"397","author":"Okuda","year":"1999"},{"key":"10.2332\/allergolint.O-08-533_bb0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2332\/allergolint.O-07-515","article-title":"Therapeutic effect of montelukast, a cysteinyl leukotriene receptor 1 anatagonist, on Japanese patients with seasonal allergic rhinitis","volume":"57","author":"Okubo","year":"2008","journal-title":"Allergol Int"},{"key":"10.2332\/allergolint.O-08-533_bb0040","first-page":"47","article-title":"Clinical assessment of pranlukast\u2014A multicenter, collaborative, double blind study using epinastine hydrochloride as a control drug","volume":"44","author":"Okuda","year":"1998","journal-title":"Jibi to Rinsho Otologia Fukuoka"},{"key":"10.2332\/allergolint.O-08-533_bb0045","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S1081-1206(10)61891-1","article-title":"Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall","volume":"88","author":"Nayak","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.2332\/allergolint.O-08-533_bb0050","series-title":"Pollen Information Report","year":"2004"},{"key":"10.2332\/allergolint.O-08-533_bb0055","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1046\/j.1365-2222.2002.01422.x","article-title":"Montelukast for treating seasonal allergic rhinitis: a randomized, double- blind, placebo-controlled trial performed in the spring","volume":"32","author":"Philip","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.2332\/allergolint.O-08-533_bb0060","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/S1081-1206(10)62144-8","article-title":"Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis","volume":"90","author":"van Adelsberg","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.2332\/allergolint.O-08-533_bb0065","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1046\/j.1398-9995.2003.00261.x","article-title":"Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period","volume":"12","author":"van Adelsberg","year":"2003","journal-title":"Allergy"},{"key":"10.2332\/allergolint.O-08-533_bb0070","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1185\/030079904X3348","article-title":"The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis","volume":"20","author":"Philip","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.2332\/allergolint.O-08-533_bb0075","first-page":"41","article-title":"Onset of efficacy of montelukast in seasonal allergic rhinitis","volume":"26","author":"Weinstein","year":"2005","journal-title":"Allergy Asthma Proc"}],"container-title":["Allergology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015308029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1323893015308029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T04:45:59Z","timestamp":1557981959000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1323893015308029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"alternative-id":["S1323893015308029"],"URL":"https:\/\/doi.org\/10.2332\/allergolint.o-08-533","relation":{},"ISSN":["1323-8930"],"issn-type":[{"value":"1323-8930","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}